Analyst Opinions: Changes for Safran, BNP Paribas, Sanofi...
Target price raises (Sanofi, Legrand, L'Oréal, Arcadis) are mixed with cuts (Kering, Teleperformance, Avantium). Several brokers confirm their rating while adjusting their target price.
Above their target: 9 stocks · SBF 120 stocks covered: 120
Stocks trading above their target: Eurofins Scientific (-16.6%) · Air France-KLM (-11.6%) · Teleperformance (-9.5%) · Icade (-9.3%) · Dassault Systèmes (-6.2%) · Rémy Cointreau (-6.1%) · bioMérieux (-2.5%) · Métropole Télévision (-2.3%) · Sodexo (-0.2%)
Sanofi: Exane BNP Paribas upgrades from “neutral” to “outperform” and raises its target from 79 to 102 euros. UBS remains at “hold” and lifts it from 78 to 88 euros. One analyst had raised its target on November 6. Median at 90 euros, gap between targets and share price: +5%.
From 143 to 146 euros at Legrand for BofA Securities, still at “sell”. UBS, meanwhile, moves from “hold” to “buy” with a target raised from 160 to 170 euros. 2 analysts had raised their targets on November 6. Median target at 171 euros, gap between targets and share price: +29%.
At Kering, the target falls on both sides: Kepler Cheuvreux remains at “buy” and cuts it from 340 to 300 euros, while Morgan Stanley, at “equal-weight”, sets it at 200 euros versus 220 euros previously. One analyst had already lowered its target on November 6. Median at 230 euros, gap between targets and share price: +23.3%.
Société Générale sees two opposing moves: UBS, still at “buy”, lowers its target from 97 to 90 euros, while Goldman Sachs, at “neutral”, shows 82.50 euros, versus 80.75 euros until now. 2 analysts had raised their targets and 1 had lowered it, with the latest move on November 5. Median at 86.50 euros, gap between targets and share price: +33.1%.
At Kepler Cheuvreux, three stocks: ArcelorMittal, where the broker remains at “buy” and cuts its target from 72 to 70 euros (2 analysts had lowered their targets, latest move on November 6; median at 71 euros, gap between targets and share price: +26.6%); Ayvens, still at “buy”, target from 11.70 to 11.30 euros (median at 10.80 euros, gap between targets and share price: +11.2%); Ipsen, where it remains at “hold” and raises its target from 165 to 169 euros (median at 169 euros, gap between targets and share price: +4.2%).
Another move at Kepler Cheuvreux: bioMérieux moves from “buy” to “hold” with its target raised from 85 to 95 euros. 7 analysts had raised their targets, latest move on November 5. Median at 90 euros, gap between targets and share price: -2.5%.
BNP Paribas: BNP Paribas sees UBS, still at “buy”, lowering its target from 119 to 111 euros. 3 analysts had raised their targets and 1 had lowered it, latest move on November 6. Median at 118 euros, gap between targets and share price: +27%.
UBS also adjusts Safran: the broker confirms its “hold” rating and cuts its target from 350 to 330 euros. 2 analysts had lowered their targets, latest move on November 2. Median at 345 euros, gap between targets and share price: +15.5%.
It is the day's sharp increase: from 42 to 56 euros at Arcadis, where ING remains at “buy”. One analyst had raised its target on November 2. Median at 48 euros, gap between targets and share price: +2.1%.
Teleperformance: BofA Securities, still at “hold”, cuts its target from 76 to 67 euros. One analyst had raised its target and 2 had lowered it, latest move on November 6. Median at 62 euros, gap between targets and share price: -9.5%.
On November 6, one analyst had raised its target on Publicis Groupe and another had lowered it. Today, Deutsche Bank remains at “hold” and raises its target from 90 to 100 euros. Median at 116.50 euros, gap between targets and share price: +13%.
Philips: BofA Securities, still at “hold”, raises its target from 26 to 29 euros. 2 analysts had raised their targets, latest move on November 4. Median at 26 euros, gap between targets and share price: -4.8%.
At Galp Energia, Morgan Stanley moves from “buy” to “hold” and cuts its target from 24 to 23 euros. Median at 23 euros, gap between targets and share price: +20.1%.
From 80 to 87 euros at TotalEnergies: LBBW moves from “hold” to “buy”. 2 analysts had raised their targets, latest move on November 6. Median at 89.50 euros, gap between targets and share price: +13.3%.
For L'Oréal, Rothschild & Co Redburn is at “buy”, with a target of 465 euros versus 415 euros previously. One analyst had raised its target on October 30. Median at 455 euros, gap between targets and share price: +2%.
Ackermans & van Haaren: KBC Securities remains at “buy” and raises its target from 320 to 330 euros. Median at 310 euros, gap between targets and share price: +15.3%.
Same move at Solvay: ING, still at “hold”, lowers its target from 26 to 25 euros, while Berenberg is at “hold” with an unchanged target of 24.50 euros. One analyst had lowered its target on November 5. Median at 25 euros, gap between targets and share price: +1.2%.
Stellantis: Evercore ISI is at “in line”, with a target of 4.50 euros versus 5.50 euros previously. Median at 4.50 euros, gap between targets and share price: +13%.
At Engie, Goldman Sachs is at “buy” with a target raised from 30.40 to 31.80 euros. One analyst had lowered its target on November 6. Median at 30 euros, gap between targets and share price: +21.7%.
Dassault Systèmes: Goldman Sachs is at “neutral”, with a target of 24 euros versus 21 euros previously. Median at 24.50 euros, gap between targets and share price: -6.2%.
On Worldline, Citi is at “neutral” with a target of 12.50 euros. One analyst had lowered its target on November 3. Median at 11.70 euros, gap between targets and share price: +1.3%.
Severe cut at Avantium: Stifel remains at “buy” but cuts its target from 49 to 20 euros. Median at 4.37 euros, gap between targets and share price: +112.7%.
AMG: Deutsche Bank remains at “buy” and lowers its target from 42 to 34 euros. Median at 45 euros, gap between targets and share price: +92.8%.
At Aperam, two brokers cut their targets: Deutsche Bank, at “buy”, from 66 to 63 euros, and JP Morgan, which remains at “overweight”, from 55.50 to 49.90 euros. Median at 47 euros, gap between targets and share price: +44.2%.
Hexaom: Portzamparc is at “buy” with a target of 47 euros versus 55 euros previously, and TP Icap Midcap is also at “buy”, with a target of 43 euros versus 47 euros. Median at 47 euros, gap between targets and share price: +123.8%.
In small caps, Claranova sees Oddo BHF remain at “hold” and cut its target from 1 to 0.70 euro (median at 2.60 euros, gap between targets and share price: +422.1%), while at Nyxoah, Invest Securities remains at “buy” with an unchanged target of 3 euros (median at 4.30 euros, gap between targets and share price: +451.3%).
